Clinical Trial

Evaluation of Intra-articular CX-011 to Treat Moderate to Severe Pain From Knee Osteoarthritis

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
Study is designed to evaluate the safety and effectiveness of a drug called CX-011 to treat pain in patients with osteoarthritis of the knee. Osteoarthritis produces pain in the knee (and other joints) that typically is worsened by activities such as long distance walking and is alleviated by rest.
Protocol Amendment History 1 change
critical Recruitment opened 2026-08-14
Trial Details
NCT Number NCT07308834
Lead Sponsor CarthroniX, Inc.
Conditions Osteoarthritis of the Knees
Enrollment 72 participants
Start Date 2026-08-11
Primary Completion 2028-10-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-13